{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-119532","form_type":"8-K","ticker":"GANX","cik":"0001819411","company_name":"Gain Therapeutics, Inc.","filed_at":"2023-11-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.661027+00:00","generated_at":"2026-06-08T00:20:48.719351+00:00","sec_items":["1.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Gain Therapeutics terminates at-the-market offering agreement with Cantor Fitzgerald","bullets":["Terminated Controlled Equity Offering Sales Agreement with Cantor Fitzgerald effective Nov 13, 2023.","Agreement allowed for at-the-market sales; 865,535 shares sold for net proceeds of $3.5M total.","Company gave immediate notice; no reason for termination provided in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-119532","json":"https://secwatch.observer/filing/0001104659-23-119532.json","markdown":"https://secwatch.observer/filing/0001104659-23-119532.md","text":"https://secwatch.observer/filing/0001104659-23-119532.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819411/000110465923119532/0001104659-23-119532-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819411/000110465923119532/tm2330139d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T00:20:48.719351+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"010f8af37c0067c2e39fe320c1d55ff088c37909","claim":"Gain Therapeutics, Inc. terminated Sales Agreement with Cantor Fitzgerald & Co. (effective 2023-11-13).","evidence_excerpt":"On November 13, 2023, Gain Therapeutics, Inc. (the “ Company ”) notified Cantor Fitzgerald & Co. (“ Cantor ”) of its decision to terminate the Controlled Equity Offering SM Sales Agreement, dated as of May 18, 2022, (the “ Sales Agreement ”) between the Company and Cantor, effective immediately (the “ Termination Date ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1819411/000110465923119532/0001104659-23-119532-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"Cantor Fitzgerald & Co."},{"label":"Effective","value":"2023-11-13"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}